CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology
Maya Anne Ellisman, Floyd Sarsoza, Robert A Rissman · 2025
Read CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology by Maya Anne Ellisman, Floyd Sarsoza, Robert A Rissman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710354.txt.
Description
Maya Anne Ellisman, Floyd Sarsoza, and Robert Rissman test a stress-system blocker in young mice bred for Alzheimer's disease, with and without chronic stress, in a 2025 study. The drug blocks CRFR1, a receptor for a stress hormone signal long tied to Alzheimer hallmarks. Six-month-old mice got the drug or a dummy treatment alongside restraint stress.
Blockade improved learning and mental flexibility, cut plaques across memory regions, and lowered the most toxic soluble amyloid forms. Stress alone, surprisingly, helped learning too, while shifting plaque patterns by region. Drug plus stress sharpened the learning gain but erased the memory effect of stress, and shuffled cortical amyloid again. The authors see early stress-system treatment as a plausible prevention angle.
Catalog record
| CREATOR | Maya Anne Ellisman, Floyd Sarsoza, Robert A Rissman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |